無針デバイス：各種技術と世界市場

世界の無針デバイスの市場規模は、2024年の155億米ドル、2025年の170億米ドルから、2025年から2030年にかけてはCAGR 10.2%で推移し、2030年には277億米ドルに達すると予測されています。

北米市場は、2024年の67億米ドル、2025年の74億米ドルから、2025年から2030年にかけてはCAGR 10.4%で推移し、2030年には121億米ドルに達すると予測されています。アジア太平洋地域の市場は、2024年の25億米ドル、2025年の28億米ドルから、CAGR 12.1%で推移し、2030年には50億米ドルに達すると予測されています。

当レポートでは、世界の無針デバイスの市場を調査し、市場概要、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析などをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場サマリー

第2章 市場概要

• 概要
• マクロ経済要因
• 米国の関税が医薬品・医療機器業界に与える影響
• 人口動態と高齢化
• 医療インフラと支出
• 規制と政策の情勢
• 技術の進歩と資金調達
• 地政学的リスク、貿易戦争、サプライチェーンの混乱
• ポーターのファイブフォース分析

第3章 市場力学

• 概要
• 市場促進要因
• 針刺し事故の増加
• 痛みのないドラッグデリバリーの優先
• 在宅医療と自己管理の需要
• 市場抑制要因
• 無針技術のコスト
• 大容量および静脈内投与システムの限界
• 市場機会
• 製品イノベーション
• 新興市場におけるヘルスケアへの投資増加

第4章 規制状況

• 概要
• 米国の規制シナリオ
• 欧州の規制シナリオ
• 日本の規制シナリオ
• 中国の規制シナリオ
• FDA承認の吸入器
• FDA承認の経皮パッチ

第5章 新たな動向とパイプライン分析

• 新たな動向
• スマートパッチ
• スマート吸入器
• ソノフォレシス
• 3Dプリントマイクロアレイパッチ
• 溶解性/分解性パッチ
• パイプライン分析
• サマリー
• 特許分析
• 吸入器技術
• 経皮パッチ
• 無針注射器
• 調査結果

第6章 市場セグメンテーション分析

• セグメンテーションの内訳
• 市場内訳：製品タイプ別
• サマリー
• 吸入器技術
• 経皮パッチ
• 無針注射器
• その他
• 市場内訳：用途別
• サマリー
• ワクチン
• 疼痛管理
• インスリン投与
• 小児ドラッグデリバリー
• その他
• 市場内訳：エンドユーザー別
• サマリー
• 病院と診療所
• 在宅ケア設定
• 調査・学術機関
• 地理的内訳
• 市場内訳：地域別
• 重要ポイント
• 北米
• 欧州
• アジア太平洋
• 南米
• 中東・アフリカ

第7章 競合情報

• サマリー
• 主要企業の市場シェア
• 戦略分析

第8章 無針デバイスの持続可能性：ESGの観点

• 概要
• 環境の持続可能性
• 社会的責任
• ガバナンスの観点
• ESGリスク評価
• BCCによる結論

第9章 付録

• 調査手法
• 出典
• 略語
• 企業プロファイル
• AKRA DERMOJET
• APTARGROUP INC.
• ARX LLC.
• ASTRAZENECA
• AVAXZIPEN
• CROSSJECT
• ENDO INC.
• GSK PLC.
• HALOZYME INC.
• MIKA MEDICAL CO.
• NOVARTIS AG
• NUGEN MEDICAL DEVICES
• PHARMAJET
• PRESSPART VERWALTUNGS GMBH
• VIATRIS INC.
• 新興スタートアップ企業/市場ディスラプター

List of Tables

• Summary Table : Global Market for Needle-Free Devices, by Region, Through 2030
• Table 1 : FDA Device Classifications
• Table 2 : Approved Inhalers
• Table 3 : FDA-Approved Transdermal Products
• Table 4 : Pipeline Drugs for Needle-Free Devices
• Table 5 : Granted Patents for Inhaler Technologies, 2022-2025
• Table 6 : Granted Patents for Transdermal Patches, 2022-2025
• Table 7 : Granted Patents for Needle-Free Injectors, 2022-2025
• Table 8 : Global Market for Needle-Free Devices, by Product Type, Through 2030
• Table 9 : Global Market for Inhaler Technologies, by Type, Through 2030
• Table 10 : Global Market for Inhaler Technologies, by Region, Through 2030
• Table 11 : Drug Used in Transdermal Patches/Products
• Table 12 : Global Market for Transdermal Patches, by Region, Through 2030
• Table 13 : Comparison of the Three Medication Types of Needle-Free Injectors
• Table 14 : Global Market for Needle-free Injectors, by Medication Type, Through 2030
• Table 15 : Global Market for Needle-free Injectors, by Drug Delivery, Through 2030
• Table 16 : Global Market for Needle-free Injectors, by Region, Through 2030
• Table 17 : Global Market for Other Novel Needle-free Technologies, by Region, Through 2030
• Table 18 : Global Market for Needle-Free Devices, by Application, Through 2030
• Table 19 : Global Market for Needle-Free Devices, by End User, Through 2030
• Table 20 : Global Market for Needle-Free Devices, by Region, Through 2030
• Table 21 : North American Market for Needle-Free Devices, by Product Type, Through 2030
• Table 22 : North American Market for Needle-Free Devices, by Country, Through 2030
• Table 23 : U.S. Market for Needle-Free Devices, by Product Type, Through 2030
• Table 24 : Canadian Market for Needle-Free Devices, by Product Type, Through 2030
• Table 25 : Mexican Market for Needle-Free Devices, by Product Type, Through 2030
• Table 26 : European Market for Needle-Free Devices, by Product Type, Through 2030
• Table 27 : European Market for Needle-Free Devices, by Country, Through 2030
• Table 28 : German Market for Needle-Free Devices, by Product Type, Through 2030
• Table 29 : U.K. Market for Needle-Free Devices, by Product Type, Through 2030
• Table 30 : French Market for Needle-Free Devices, by Product Type, Through 2030
• Table 31 : Spanish Market for Needle-Free Devices, by Product Type, Through 2030
• Table 32 : Italian Market for Needle-Free Devices, by Product Type, Through 2030
• Table 33 : Rest of European Market for Needle-Free Devices, by Product Type, Through 2030
• Table 34 : Asia-Pacific Market for Needle-Free Devices, by Product Type, Through 2030
• Table 35 : Asia-Pacific Market for Needle-Free Devices, by Country, Through 2030
• Table 36 : Chinese Market for Needle-Free Devices, by Product Type, Through 2030
• Table 37 : Japanese Market for Needle-Free Devices, by Product Type, Through 2030
• Table 38 : Indian Market for Needle-Free Devices, by Product Type, Through 2030
• Table 39 : Rest of Asia-Pacific Market for Needle-Free Devices, by Product Type, Through 2030
• Table 40 : South American Market for Needle-Free Devices, by Product Type, Through 2030
• Table 41 : South American Market for Needle-Free Devices, by Country, Through 2030
• Table 42 : Brazilian Market for Needle-Free Devices, by Product Type, Through 2030
• Table 43 : Argentine Market for Needle-Free Devices, by Product Type, Through 2030
• Table 44 : Rest of South American Market for Needle-Free Devices, by Product Type, Through 2030
• Table 45 : MEA Market for Needle-Free Devices, by Product Type, Through 2030
• Table 46 : MEA Market for Needle-Free Devices, by Subregion, Through 2030
• Table 47 : Middle East Market for Needle-Free Devices, by Product Type, Through 2030
• Table 48 : African Market for Needle-Free Devices, by Product Type, Through 2030
• Table 49 : Recent Developments in the Needle-free Device Industry
• Table 50 : ESG Risk Rankings for Needle-Free Device Companies, 2024*
• Table 51 : Information Sources Used in this Report
• Table 52 : Abbreviations Used in this Report
• Table 53 : Akra Dermojet: Company Snapshot
• Table 54 : Akra Dermojet: Product Portfolio
• Table 55 : AptarGroup Inc.: Company Snapshot
• Table 56 : AptarGroup Inc.: Financial Performance, FY 2023 and 2024
• Table 57 : AptarGroup Inc.: Product Portfolio
• Table 58 : AptarGroup Inc.: News/Key Developments, 2022-2024
• Table 59 : ARx LLC.: Company Snapshot
• Table 60 : ARx LLC: Product Portfolio
• Table 61 : AstraZeneca: Company Snapshot
• Table 62 : AstraZeneca: Financial Performance, FY 2023 and 2024
• Table 63 : AstraZeneca: Product Portfolio
• Table 64 : AstraZeneca: News/Key Developments, 2023 and 2024
• Table 65 : aVaxziPen: Company Snapshot
• Table 66 : aVaxziPen: Product Portfolio
• Table 67 : aVaxziPen: News/Key Developments, 2024
• Table 68 : CROSSJECT: Company Snapshot
• Table 69 : CROSSJECT: Financial Performance, FY 2023 and 2024
• Table 70 : CROSSJECT: Product Portfolio
• Table 71 : CROSSJECT: News/Key Developments, 2023-2025
• Table 72 : Endo Inc.: Company Snapshot
• Table 73 : Endo Inc.: Financial Performance, FY 2023 and 2024
• Table 74 : Endo Inc.: Product Portfolio
• Table 75 : Endo Inc.: News/Key Developments, 2025
• Table 76 : GSK plc.: Company Snapshot
• Table 77 : GSK Plc.: Financial Performance, FY 2023 and 2024
• Table 78 : GSK Plc.: Product Portfolio
• Table 79 : GSK Plc.: News/Key Developments, 2025
• Table 80 : Halozyme Inc.: Company Snapshot
• Table 81 : Halozyme Inc.: Financial Performance, FY 2023 and 2024
• Table 82 : Halozyme Inc.: Product Portfolio
• Table 83 : Halozyme Inc.: News/Key Developments, 2023-2025
• Table 84 : MIKA MEDICAL CO.: Company Snapshot
• Table 85 : MIKA MEDICAL CO: Product Portfolio
• Table 86 : Novartis AG: Company Snapshot
• Table 87 : Novartis AG: Financial Performance, FY 2023 and 2024
• Table 88 : Novartis AG: Product Portfolio
• Table 89 : Novartis AG: News/Key Developments, 2020
• Table 90 : NuGen Medical Devices: Company Snapshot
• Table 91 : NuGen Medical Devices: Financial Performance, FY 2023 and 2024
• Table 92 : NuGen Medical Devices: Product Portfolio
• Table 93 : NuGen Medical Devices: News/Key Developments, 2023-2025
• Table 94 : PharmaJet: Company Snapshot
• Table 95 : PharmaJet: Product Portfolio
• Table 96 : PharmaJet: News/Key Developments, 2023-2024
• Table 97 : Presspart Verwaltungs GmbH: Company Snapshot
• Table 98 : Presspart Verwaltungs GmbH: Product Portfolio
• Table 99 : Presspart Verwaltungs GmbH.: News/Key Developments, 2023 and 2024
• Table 100 : Viatris Inc.: Company Snapshot
• Table 101 : Viatris Inc.: Financial Performance, FY 2023 and 2024
• Table 102 : Viatris Inc.: Product Portfolio
• Table 103 : Viatris Inc.: News/Key Developments, 2022
• Table 104 : Emerging Startups

List of Figures

• Summary Figure : Global Market Shares of Needle-Free Devices, by Region, 2024
• Figure 1 : Porter's Five Forces Analysis
• Figure 2 : Market Dynamics of Needle-Free Devices
• Figure 3 : Needlestick Injuries in Hospitals, by Department
• Figure 4 : Patents for Inhaler Technologies, 2022-2025
• Figure 5 : Patents for Transdermal Patches, 2022-2025
• Figure 6 : Patents for Needle-Free Injectors, 2022-2025
• Figure 7 : Global Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 8 : Global Market Shares of Inhaler Technologies, by Region, 2024
• Figure 9 : Global Market Shares of Transdermal Patches, by Region, 2024
• Figure 10 : Global Market Shares of Needle-free Injectors, by Region, 2024
• Figure 11 : Global Market Shares of Other Novel Needle-free Technologies, by Region, 2024
• Figure 12 : Global Market Shares of Needle-Free Devices, by Application, 2024
• Figure 13 : Global Market Shares of Needle-Free Devices, by End User, 2024
• Figure 14 : Global Market Shares of Needle-Free Devices, by Region, 2024
• Figure 15 : North American Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 16 : North American Market Shares of Needle-Free Devices, by Country, 2024
• Figure 17 : U.S. Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 18 : Canadian Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 19 : Mexican Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 20 : European Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 21 : European Market Shares of Needle-Free Devices, by Country, 2024
• Figure 22 : German Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 23 : U.K. Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 24 : French Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 25 : Spanish Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 26 : Italian Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 27 : Rest of European Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 28 : Asia-Pacific Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 29 : Asia-Pacific Market Shares of Needle-Free Devices, by Country, 2024
• Figure 30 : Chinese Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 31 : Japanese Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 32 : Indian Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 33 : Rest of Asia-Pacific Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 34 : South American Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 35 : South American Market Shares of Needle-Free Devices, by Country, 2024
• Figure 36 : Brazilian Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 37 : Argentine Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 38 : Rest of South American Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 39 : MEA Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 40 : MEA Market Shares of Needle-Free Devices, by Subregion, 2024
• Figure 41 : Middle East Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 42 : African Market Shares of Needle-Free Devices, by Product Type, 2024
• Figure 43 : Needle-Free Device Makers Global Market Shares, 2024
• Figure 44 : AptarGroup Inc.: Revenue Share, by Business Unit, FY 2024
• Figure 45 : AptarGroup Inc.: Revenue Share, by Region/Country, FY 2024
• Figure 46 : ASTRAZENECA: Revenue Share, by Business Unit, FY 2024
• Figure 47 : ASTRAZENECA: Revenue Share, by Region/Country, FY 2024
• Figure 48 : Endo Inc.: Revenue Share, by Business Unit, FY 2024
• Figure 49 : GSK Plc.: Revenue Share, by Business Unit, FY 2024
• Figure 50 : GSK Plc.: Revenue Share, by Country/Region, FY 2024
• Figure 51 : Halozyme Inc.: Revenue Share, by Business Unit, FY 2024
• Figure 52 : Halozyme Inc.: Revenue Share, by Country/Region, FY 2024
• Figure 53 : Novartis AG: Revenue Share, by Business Unit, FY 2024
• Figure 54 : Novartis AG: Revenue Share, by Country/Region, FY 2024
• Figure 55 : Viatris Inc.: Revenue Shares, by Business Unit, FY 2024
• Figure 56 : Viatris Inc.: Revenue Shares, by Country/Region, FY 2024

The global market for needle-free devices was valued at $15.5 billion in 2024 and is estimated to increase from $17.0 billion in 2025 to reach $27.7 billion by 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 through 2030.

The North American market for needle-free devices was valued at $6.7 billion in 2024 and is estimated to increase from $7.4 billion in 2025 to reach $12.1 billion by 2030, at a CAGR of 10.4% from 2025 through 2030.

The Asia-Pacific market for needle-free devices was valued at $2.5 billion in 2024 and is estimated to increase from $2.8 billion in 2025 to reach $5.0 billion by 2030, at a CAGR of 12.1% from 2025 through 2030.

Report Scope

Both qualitative and quantitative data on the current market dynamics and trends are presented in this report on the global market for needle-free devices. The report also assesses recent technological developments and product performance. Analyses of the most popular products, clinical trials, new product approvals, and emerging technologies are also included. The market prospects for five regions-North America, Europe, Asia-Pacific, South America, and the Middle East and Africa (MEA)-are discussed. The report also includes profiles of leading companies and their strategies.

The global market is segmented into the following product types: needle-free injectors, inhaler technologies, transdermal patch technologies and other novel technologies. By application, the market is segmented into vaccines, pain management, insulin delivery, pediatric injections and others. By end-user, the market is segmented into hospitals and clinics, homecare settings, and research and academic institutions. For market estimates, data has been provided for 2024 as the base year, with forecasts for 2025 through 2030.

Report Includes

• 49 data tables and 56 additional tables
• An overview of the global market for needle-free devices and technologies
• Analyses of global market trends with data from 2022 to 2025 and projected CAGRs through 2030
• Highlights of the current and future market potential and quantification of the market by product type, application, end user and region
• Assessment of the recent developments, key technological updates and product performance within the needle-free devices market
• Insight into various needle-free technologies that are used in drug delivery and their application areas
• Discussion of government regulations that can affect the global needle-free devices market
• Identification of challenges and discussion on how to overcome those to reach its commercialization potential, and ESG trends of the market
• Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
• Company profiles of major players within the industry, including GSK plc., Novartis AG, Viatris Inc., and PharmaJet

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Macroeconomic Factors
• Impact of U.S. Tariffs on the Pharmaceutical and Medical Device Industries
• Population Demographics and Aging Populations
• Healthcare Infrastructure and Spending
• Regulatory and Policy Landscape
• Technological Advances and Funding
• Geopolitical Risks, Trade Wars, and Supply Chain Disruptions
• Porter's Five Forces Analysis
• Potential for New Entrants (Moderate to High)
• Bargaining Power of Suppliers (Low to Moderate)
• Bargaining Power of Buyers (Moderate to High)
• Threat of Substitute Products or Services (High)
• Industry Level of Competitiveness (Moderate to High)

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Increasing Incidence of Needlestick Injuries
• Preference for Painless Drug Delivery
• Demand for Home Healthcare and Self-Administration
• Market Restraints
• Cost of Needle-Free Technology
• Limitations of Large Volume and Intravenous Administration Systems
• Market Opportunities
• Product Innovation
• Increased Investments in Healthcare in Emerging Markets

Chapter 4 Regulatory Landscape

• Overview
• Regulatory Scenario in the U.S.
• Regulatory Scenario in Europe
• Regulatory Scenario in Japan
• Regulatory Scenario in China
• FDA-Approved Inhalers
• FDA-Approved Transdermal Patch

Chapter 5 Emerging Trends and Pipeline Analysis

• Emerging Trends
• Smart Patches
• Smart Inhalers
• Sonophoresis
• 3D-Printed Microarray Patches
• Dissolving/Degradable Patches
• Pipeline Analysis
• Takeaways
• Patent Analysis
• Inhaler Technologies
• Transdermal Patches
• Needle-Free Injectors
• Findings

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Breakdown by Product Type
• Takeaways
• Inhaler Technologies
• Transdermal Patches
• Needle-free Injectors
• Other Novel Technologies
• Market Breakdown by Application
• Takeaways
• Vaccines
• Pain Management
• Insulin Delivery
• Pediatric Drug Delivery
• Other Applications
• Market Breakdown by End-User
• Takeaways
• Hospital and Clinics
• Homecare Settings
• Research and Academic Institutions
• Geographic Breakdown
• Market Breakdown by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 7 Competitive Intelligence

• Takeaways
• Market Shares of Leading Companies
• Strategic Analysis

Chapter 8 Sustainability in Needle-Free Devices: ESG Perspective

• Overview
• Environmental Sustainability
• Social Responsibility
• Governance Perspective
• ESG Risk Ratings
• Concluding Remarks from BCC Research

Chapter 9 Appendix

• Research Methodology
• Sources
• Abbreviations
• Company Profiles
• AKRA DERMOJET
• APTARGROUP INC.
• ARX LLC.
• ASTRAZENECA
• AVAXZIPEN
• CROSSJECT
• ENDO INC.
• GSK PLC.
• HALOZYME INC.
• MIKA MEDICAL CO.
• NOVARTIS AG
• NUGEN MEDICAL DEVICES
• PHARMAJET
• PRESSPART VERWALTUNGS GMBH
• VIATRIS INC.
• Emerging Start-ups/Market Disruptors